Zack Devier

Chief Executive OfficeratPrescient Strategies
LinkedIn ↗
zdevier@prescient-strategies.comvalid
AuditAnyMailFinderNeverBounceScrubbyvalid
LI CopyInvite SentAcceptedDM Sent|Email CopyCampaign|No Response

LinkedIn Copy

Connection Request

Hey Zack — congrats on launching Prescient Strategies. came from a similar background (banking → growth equity) and been thinking a lot about PE origination lately. would be good to connect.

Cold DM (Sales Nav)

Hey Zack, similar path — banking into PE, though I was in London at Credit Suisse & Greenhill not in commercial real estate underwriting like you. origination was always the same story for me — clear thesis, decent relationships, but no proprietary system of record tying anything together. every deal sourced from scratch, nothing compounding over time. curious if that's still how most funds operate or if I'm behind the times? — Russ

Accept DM

Hey Zack, looks like we share a similar finance-to-PE path, though I was in London doing growth equity deals at Treis not in Greenville building a multi-strategy family office like you. the pattern I keep seeing with most funds is weirdly consistent — strong thesis, solid network, but no proprietary system of record. the people, tools and ideas are never really connected. every deal virtually sourced from scratch, nothing compounds on itself. curious if that resonates or if you've built something different at Prescient? — Russ

Followup 1

hey Zack — no worries if the timing's off. most funds I talk to have tried some version of building origination in-house — analyst pulling from Pitchbook, maybe using ChatGPT to help qualify, dumping it into a spreadsheet. each piece kind of works, but there's no system of record tying it together. the people, tools and ideas stay disconnected, so there's tonnes of wasted energy. been helping a few funds like Mentmore Capital work through that. curious if you've run into the same thing at Prescient? — Russ

Followup 2 (Breakup)

totally get it if origination infrastructure isn't top of mind right now — most funds have 10 things ahead of it on the priority list. the funds I've seen crack it early just tend to compound deal flow in a way that's hard to replicate later. if it ever moves up the list, I'm easy to find. — Russ

Email Copy

No email copy generated yet.

Prospect Research

Research Notes

## PROSPECT INFORMATION: Name: Zack Devier Title: Chief Executive Officer Fund: Prescient Strategies Background: Prospect: Zack Devier Current Role: Entrepreneur and multi-entity leader based in Greenville, South Carolina. He currently serves as the CEO of Prescient Strategies (since January 2024), a Venture Capital & Private Equity firm, and Chairman of the Board for OnPoint CFO & Controller Services (since June 2024). He also maintains a long-standing position as a Board Member at Armada Analytics, Inc. (since 2006). Background: Zack is a seasoned real estate and finance professional with over 25 years of experience. His career began in underwriter roles at GMAC Commercial Mortgage and Standard Mortgage Corporation, eventually rising to Deputy Chief Underwriter at Column Financial. He holds a BBA in Real Estate & Finance from Georgia State University, an MS in Finance from Georgetown University (2023), and is currently engaged in Executive Education at Harvard Business School. Key Skills: Commercial Real Estate, Underwriting, Asset Management, Real Estate Economics, Financial Valuation, and Strategic Leadership. Recent Activity and Post Quotes: Zack is highly active in promoting financial clarity and strategic growth for business owners. March 11, 2026: Zack highlighted the financial stress of business expansion, stating, "Growth decisions happen before the results show up. Owners must decide today based on what they believe will happen tomorrow." He emphasized that "Growth should feel like a strategy. Not a gamble." February 27, 2026: Zack was a featured speaker at the "OnPoint Connect – Lunch & Learn." A post regarding the event noted his insights on the "pressure that comes with transition" and the core theme that "Transitions don’t succeed because of timing alone. They succeed because the right team is in place long before the transition begins." February 20, 2026: Zack announced the launch of the Prescient Market Digest, aimed at covering macroeconomics and geopolitical impacts on markets. The post stated he is "excited to release the first edition... covering geopolitical conflicts, macroeconomics, Uber's robotaxi push, Nvidia's continued success, and global stocks' outperformance." February 9, 2026: Zack shared his philosophy on client onboarding, noting that "We begin with questions... How does your business actually work? What are you trying to build? What keeps you up at night? Because numbers don’t mean much on their own. They only matter when they’re tied to your goals." February 5, 2026: He addressed the root of financial anxiety, writing, "Most financial pressure doesn’t come from bad months. It comes from not seeing them coming... Predictability doesn’t limit growth. It enables it." January 28, 2026: Zack discussed a successful client transformation from "financial confusion to strategic clarity" by moving from cash to accrual basis accounting, concluding that "Accurate numbers don't automatically create good decisions, but trusted numbers do." Fund details: - Description: With a focus on partnering with promising private companies, we leverage our expertise to drive operational excellence, foster growth, and optimize performance. Our commitment to maximizing shareholder value positions us as a trusted partner for investors seeking impactful returns. At Prescient Strategies, we combine financial acumen with a hands-on approach to unlock untapped potential and create lasting success for our portfolio companies. - Website: https://prescient-strategies.com - Location: Greenville, South Carolina, United States - Lead qualification: Research: - Query: =Prescient Strategies Zack Devier recent investments fund thesis - Answer: Zack Devier, associated with Prescient Strategies, recently invested in Transcend, a company conducting clinical trials for a new empathogen. This investment highlights his focus on innovative medical research.

Activity

LI Copy GeneratedDone
LI DMDone
DM Sent Date12/03/2026
Sales NavYes
ID: 2754Airtable: recrJzx8f7xjr2QFXURN: 41434701